Revolution Medicines GAAP EPS of -$1.90 beats by $0.50, revenue of $197.5M beats by $170.15M
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking AlphaRelated stories
Qualcomm stock drops 6% on weak earnings forecast as memory shortage weighs on smartphone sales
CNBC · 2 min ago
Compass Diversified GAAP EPS of $0.05 beats by $0.40, revenue of $422.9M beats by $12.38M
Seeking Alpha · 3 min ago
North Korea is likely culprit behind $6.3bn crypto hack, ‘largest heist in history’
Dev.to · 4 min ago
Root GAAP EPS of $0.86 beats by $0.21, revenue of $381.3M misses by $1.64M
Seeking Alpha · 4 min ago
nDatalyze terminates proposed reverse takeover deal with Prism Diversified
Seeking Alpha · 4 min ago
Vir Biotechnology Non-GAAP EPS of -$0.57 beats by $0.18
Seeking Alpha · 5 min ago